Xylocaine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

48 Suppliers, 13 USDMF, 8 CEP/COS, 3 JDMF, 9 EU WC, 12 KDMF, 29 NDC API, 35 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

382 Dossiers, 225 FDA Orange Book, 48 Europe, 63 Canada, 15 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 4%, INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 2%, INJECTABLE;SPINAL - 5%, JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

Suppliers, 43 BASF, 25 Seppic, 22 Actylis, 21 Roquette, 18 Kerry, 17 Nanjing Well Pharmaceutical, 17 Corel Pharma Chem, 13 Gangwal Chemicals, 12 SPI Pharma, 9 Microlex e.U, 9 Lubrizol Life Science Health, 6 Lonza Capsugel, 6 DKSH, 6 Rochem International Inc, 5 Finar, 4 Kima Chemical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Sigachi Industries, 4 Ideal Cures Pvt Ltd, 3 Aeon Procare, 3 Shandong Focus Biotechnology Co., Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Nanjing Bold Chemical, 3 Gangwal Healthcare, 3 Seqens, 3 The Dow Chemical Company, 3 Doshion Polyscience, 2 Nippon Fine Chemical, 2 Ingredion Pharma Solutions, 2 Nomisma Healthcare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Pharmatrans-Sanaq, 1 Clariant, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Pharm-RX Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Bioplus Life Sciences, 1 PMC Isochem, 1 BioSpectra, 1 Pfanstiehl, 1 Ulanqab Kema New Material, 1 Boai NKY Pharmaceuticals Ltd, 1 Zhejiang Huakang Pharmaceutical, 1 Jai Radhe Sales

EXCIPIENTS BY APPLICATIONS

68 Topical, 62 Solubilizers, 50 Coating Systems & Additives, 35 Parenteral, 35 Fillers, Diluents & Binders, 33 Controlled & Modified Release, 33 Thickeners and Stabilizers, 23 Film Formers & Plasticizers, 22 Emulsifying Agents, 21 Direct Compression, 18 Taste Masking, 17 Surfactant & Foaming Agents, 17 Granulation, 14 Co-Processed Excipients, 10 API Stability Enhancers, 9 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 9 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

36 US Medicaid Prescriptions, 38 Finished Drug Prices

MARKET PLACE

45 APIs, 15 DOSSIERS // FDF

PATENTS

4 US Patents

4 US Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 59 News

List of USP reference standards related to Xylocaine

Xylocaine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

48 Suppliers

13 USDMF

8 CEP/COS

3 JDMF

9 EU WC

12 KDMF

29 NDC API

35 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

382 Dossiers

225 FDA Orange Book

48 Europe

63 Canada

15 South Africa

31 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 4%

INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.005MG/ML;0.5%

INJECTABLE;INJECTION - 0.005MG/ML;1%

INJECTABLE;INJECTION - 0.005MG/ML;1.5%

INJECTABLE;INJECTION - 0.005MG/ML;2%

INJECTABLE;INJECTION - 0.01MG/ML;1%

INJECTABLE;INJECTION - 0.01MG/ML;2%

INJECTABLE;INJECTION - 0.02MG/ML;2%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 1.5%

INJECTABLE;INJECTION - 2%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 2%

INJECTABLE;SPINAL - 5%

JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

Suppliers

43 BASF

25 Seppic

22 Actylis

21 Roquette

18 Kerry

17 Nanjing Well Pharmaceutical

17 Corel Pharma Chem

13 Gangwal Chemicals

12 SPI Pharma

9 Microlex e.U

9 Lubrizol Life Science Health

6 Lonza Capsugel

6 DKSH

6 Rochem International Inc

5 Finar

4 Kima Chemical

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Sigachi Industries

4 Ideal Cures Pvt Ltd

3 Aeon Procare

3 Shandong Focus Biotechnology Co., Ltd

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Nanjing Bold Chemical

3 Gangwal Healthcare

3 Seqens

3 The Dow Chemical Company

3 Doshion Polyscience

INJECTABLE;INJECTION - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 20% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

JELLY;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons